GLP-1 weight loss patches reduced cravings during a month-long trial but caused no weight loss and remain unapproved by the ...

New research suggests GLP-1 drug tirzepatide may increase brown fat activity, helping the body burn more calories beyond reducing appetite.

Jenn Glass has been taking a GLP-1 since last November. The 53-year-old mother of three has already lost more than 30 pounds, but she's focused on something beyond the number on the scale.

Once people understood glucagonlike peptide 1 (GLP-1) drugs’ potential for weight loss, the race among pharmaceutical companies was on. Among the current options, Wegovy can help people lose an ...

This drug is different to GLP-1s, which are approved for use in the UK ...

After years of research, we finally understand how GLP-1s impact T on day 1 versus years later.

Meals and snacks with “GLP-1 Friendly” labels on the packaging are becoming more common in U.S. supermarkets as a growing number of Americans try obesity drugs like Wegovy and Zepbound to lose weight.

The study, presented at the Endocrine Society’s ENDO 2026 meeting, found tirzepatide activates brown adipose tissue. The drug is also sold under the brand names Zepbound and Mounjaro. “In the TABFAT ...

(NewsNation) — The GLP-1 medication tirzepatide may change how the body uses energy, according to new research. The study, presented at the Endocrine Society's ENDO 2026 meeting, found tirzepatide ...